Hyung D. Kook
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Real-World Efficacy and Safety of Upadacitinib in Korean Patients With Atopic Dermatitis.
Journal: Allergy, asthma & immunology research
Published: September 08, 2025
Mobile App-based Self-Monitoring of Health Behaviors in Middle-Aged Men after Myocardial Infarction: A One-Year Randomized Controlled Trial.
Journal: Asian nursing research
Published: May 09, 2025
Successful Treatment with Upadacitinib of Patient with Persistent Head and Neck Atopic Dermatitis Refractory to Dupilumab: A Case Report.
Journal: Indian journal of dermatology
Published: June 06, 2024
Atopic dermatitis treated safely with dupilumab during pregnancy and lactation: A case series of four patients.
Journal: The Australasian journal of dermatology
Published: July 07, 2023
Successful treatment of atopic dermatitis refractory to dupilumab with baricitinib.
Journal: Dermatologic therapy
Published: August 08, 2022
Baricitinib rapidly relieves eczema associated pruritus in elderly patients.
Journal: Dermatologic therapy
Published: June 07, 2022
Effect of COVID-19 (SARS-CoV-2) Vaccination on Patients with Atopic Dermatitis Treated with Dupilumab: A Multicenter, Observational Study.
Journal: Annals of dermatology
Published: May 20, 2022
The effect of baricitinib add-on therapy in atopic dermatitis patients treated with dupilumab.
Journal: Dermatologic therapy
Published: February 25, 2022
Very Early Patch Stage of AIDS-related Kaposi Sarcoma: A Case Report.
Journal: Annals of dermatology
Published: January 24, 2022
Tuberculous Lymphadenitis in a Patient Treated with Dupilumab: A Case Report.
Journal: Annals of dermatology
Published: October 21, 2021
A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world.
Journal: Scientific reports
Published: September 13, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026